• According to Oxford University Press Release Dexamethasone could cut down death rates significantly in critically ill COVID-19 patients .
  • The British government authorized the use of dexamethasone for COVID-19 patients
  • The Indian health ministry guidelines recently included the use of dexamethasone as an alternate treatment option for some COVID-19 patients showing certain specific signs of worsening status
  • Govt considering hike in API import duties.. Positive for Indian Pharma
  • The government is considering increasing the import duty on active pharmaceutical ingredients (APIs) to 20-25% from the current 10%, to help boost local manufacturing of the bulk drugs.
  • Niacinamide concentrations can be helpful in lightening dark spots.
  • The growth trajectory for the Indian pharmaceutical industry is likely to remain at 10-13 per cent in 2020-21 despite challenges, according to rating agency Icra.